Strategic Advantage Mighty Capital leverages a proprietary network of 600,000 product leaders to identify trends early, offering a differentiated edge for sourcing and diligence that can be leveraged to identify portfolio-fit startups and co-investment opportunities.

Recent Investments Active deal activity across AI-native product development, supply chain optimization, and healthcare AI platforms signals potential for cross-promotion of portfolio services and co-investment aligned with Mighty Capital’s thesis.

Platform Synergy Strong ecosystem with Products That Count and Capgemini in events and awards creates opportunities to partner on product awards programs, research briefs, and joint marketing to elevate target startups in the portfolio.

Financial Health Fund III progress with top decile DPI and TVPI indicates strong track record and liquidity, enabling discussions around follow-on rounds, SPV opportunities, and strategic exits with Mighty Capital as a lead or notable co-investor.

Strategic Partnerships Anchoring with GCM Grosvenor and a history of co-led rounds across diverse sectors suggests openings for collaboration with institutional LPs, capabilities for secondary or fund-of-funds conversations, and expanded co-investment networks.